当前位置: 首页 > 期刊 > 《婚育与健康》 > 2024年第17期
编号:2188076
亮丙瑞林微球治疗子宫内膜异位症患者的临床效果分析
http://www.100md.com 2024年9月29日 婚育与健康 2024年第17期
1资料与方法,2结果,3讨论
     【摘要】目的:分析亮丙瑞林微球治疗子宫内膜异位症患者对内分泌指标、不良反应的影响。方法:选取本院于2020年2月—2023年2月收治的82例子宫内膜异位症患者作为此次研究对象,对照组采用孕三烯酮胶囊治疗,实验组在对照组基础上采用亮丙瑞林微球治疗,比较两组治疗效果。结果:实验组治疗总有效率(95.12%)高于对照组(75.61%)(P<0.05);治疗后,实验组黄体生成素、促卵泡生成素与雌二醇均低于对照组(P<0.05);实验组不良反应发生率(7.32%)低于对照组(21.95%)(P<0.05)。结论:亮丙瑞林微球治疗子宫内膜异位症具有较好疗效,可改善内分泌指标,值得临床推广应用。

    【关键词】子宫内膜异位症;亮丙瑞林微球;临床效果

    Clinical efficacy analysis of leuprorelin microspheres in the treatment of patients with endometriosis

    ZAN Qing

    Obstetrics and Gynecology Department of the 943rd Hospital of the Joint Logistics Support Force, Wuwei, Gansu 733000, China

    【Abstract】Objective:To analyze the effects of leuprorelin microspheres on endocrine indicators and adverse reactions in patients with endometriosis.Methods:82 patients with endometriosis admitted to our hospital from February 2020 to February 2023 were selected as the study subjects.The control group was treated with gestrinone capsules,while the experimental group was treated with leuprorelin microspheres on the basis of the control group.The treatment effects of the two groups were compared.Results:The total effective rate of the experimental group (95.12%) was higher than that of the control group (75.61%) (P<0.05);After treatment ......

您现在查看是摘要页,全文长 8461 字符